MedPath

Weill Medical College Of Cornell University

Weill Medical College Of Cornell University logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1865-01-01
Employees
-
Market Cap
-
Website
http://weill.cornell.edu

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 1
Completed
Conditions
Prostate Cancer
First Posted Date
2004-07-22
Last Posted Date
2009-10-12
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
30
Registration Number
NCT00003391
Locations
🇺🇸

New York Presbyterian Hospital - Cornell Campus, New York, New York, United States

Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

Phase 2
Completed
Conditions
Esophageal Cancer
First Posted Date
2003-08-07
Last Posted Date
2009-12-08
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
39
Registration Number
NCT00066716
Locations
🇺🇸

New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States

Research Evaluating the Value of Augmenting Medication With Psychotherapy

Phase 4
Completed
Conditions
Depressive Disorder
Depression
Interventions
Behavioral: CBASP
Behavioral: Brief Supportive Psychotherapy
Drug: Medication Only
First Posted Date
2003-04-07
Last Posted Date
2017-12-06
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
491
Registration Number
NCT00057551
Locations
🇺🇸

Weill-Cornell Medical College Payne Whitney Clinic, New York, New York, United States

🇺🇸

Stanford University, Palo Alto, California, United States

🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

and more 5 locations

Study of Pharmacotherapy of Psychotic Depression

Phase 3
Completed
Conditions
Major Depressive Disorder With Psychotic Features
Interventions
First Posted Date
2003-03-17
Last Posted Date
2013-08-02
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
259
Registration Number
NCT00056472
Locations
🇺🇸

University of Massachusetts Medical School, Worcester, Massachusetts, United States

🇨🇦

University of Toronto, Toronto, Ontario, Canada

🇺🇸

Cornell University, New York, New York, United States

and more 1 locations

Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer

Phase 2
Completed
Conditions
Kidney Cancer
Interventions
Biological: recombinant interferon alfa
First Posted Date
2003-01-27
Last Posted Date
2022-03-18
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
26
Registration Number
NCT00003656
Locations
🇺🇸

New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States

🇺🇸

Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, United States

Biological Therapy in Treating Patients With Primary or Advanced Glioma

Phase 2
Suspended
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2003-01-27
Last Posted Date
2009-02-09
Lead Sponsor
Weill Medical College of Cornell University
Registration Number
NCT00003067
Locations
🇺🇸

Staten Island University Hospital, Staten Island, New York, United States

A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Weill Medical College of Cornell University
Registration Number
NCT00002407
Locations
🇺🇸

Cornell AIDS Clinical Trials Unit, New York, New York, United States

Prevention of Suicide in the Elderly

Not Applicable
Completed
Conditions
Depression
First Posted Date
1999-11-03
Last Posted Date
2013-10-29
Lead Sponsor
Weill Medical College of Cornell University
Registration Number
NCT00000367
Locations
🇺🇸

New York Presbyterian Hospital/Westchester Division, White Plains, New York, United States

© Copyright 2025. All Rights Reserved by MedPath